| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $724K | -10.6% |
| Operating Income | -$3.4M | +5.1% |
| Interest Expense | $92K | +51.8% |
| Pre-tax Income | -$2.8M | +23.3% |
| Income Tax | $0 | — |
| Net Income | -$2.8M | +23.3% |
| EPS (Diluted) | $0.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $100 | +0.0% |
| Current Assets | $102K | +46.7% |
| Total Assets | $272K | +292.2% |
| Current Liabilities | $6.6M | +23.5% |
| Total Liabilities | $6.6M | +23.5% |
| Stockholders' Equity | -$6.4M | -20.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | -60.7% |
| Investing Cash Flow | -$80K | — |
| Financing Cash Flow | $2.5M | +70.8% |
| +100.0% |